Extrarenal CYP27B1 and Vitamin D physiology martin hewison

Vitamin D: Oxidative Stress, Immunity, and Aging

Volumn , Issue , 2012, Pages 99-127

  Hewison, Martin ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85055774872     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b13714     Document Type: Chapter

References (269)

1. Holick, M. F. 2007. Vitamin D deficiency. N Engl J Med 357:266-281.
2. Holick, M. F. 2009. Vitamin D status: measurement, interpretation, and clinical application. Ann Epidemiol 19:73-78.
3. Adams, J. S. and M. Hewison. 2008. Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity. Nat Clin Pract Endocrinol Metab 4:80-90.
4. Carlberg, C. and S. Seuter. 2009. A genomic perspective on vitamin D signaling. Anticancer Res 29:3485-3493.
5. Spina, C. S., V. Tangpricha, M. Uskokovic, L. Adorinic, H. Maehr, and M. F. Holick. 2006. Vitamin D and cancer. Anticancer Res 26:2515-2524.
6. Holick, M. F. 2004. Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr 79:362-371.
7. Ross, A. C., J. E. Manson, S. A. Abrams, J. F. Aloia, P. M. Brannon, S. K. Clinton, R. A. Durazo-Arvizu, J. C. Gallagher, R. L. Gallo, G. Jones, C. S. Kovacs, S. T. Mayne, C. J. Rosen, and S. A. Shapses. 2011. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 96:53-58.
8. Krishnan, A. V. and D. Feldman. 2011. Mechanisms of the anti-cancer and anti-inflammatory actions of vitamin D. Annu Rev Pharmacol Toxicol 51:311-336.
9. Li, Y. C., G. Qiao, M. Uskokovic, W. Xiang, W. Zheng, and J. Kong. 2004. Vitamin D: A negative endocrine regulator of the renin-angiotensin system and blood pressure. J Steroid Biochem Mol Biol 89-90:387-392.
10. Brunette, M. G., M. Chan, C. Ferriere, and K. D. Roberts. 1978. Site of 1,25(OH)2 vitamin D3 synthesis in the kidney. Nature 276:287-289.
11. Zehnder, D., R. Bland, E. A. Walker, A. R. Bradwell, A. J. Howie, M. Hewison, and P. M. Stewart. 1999. Expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in the human kidney. J Am Soc Nephrol 10:2465-2473.
12. Bland, R., D. Zehnder, S. V. Hughes, P. M. Ronco, P. M. Stewart, and M. Hewison. 2001. Regulation of vitamin D-1alpha-hydroxylase in a human cortical collecting duct cell line. Kidney Int 60:1277-1286.
13. Hewison, M., D. Zehnder, R. Bland, and P. M. Stewart. 2000. 1alpha-Hydroxylase and the action of vitamin D. J Mol Endocrinol 25:141-148.
14. Haussler, M. R., C. A. Haussler, L. Bartik, G. K. Whitfield, J. C. Hsieh, S. Slater, and P. W. Jurutka. 2008. Vitamin D receptor: molecular signaling and actions of nutritional ligands in disease prevention. Nutr Rev 66:S98-S112.
15. Shimada, T., M. Kakitani, Y. Yamazaki, H. Hasegawa, Y. Takeuchi, T. Fujita, S. Fukumoto, K. Tomizuka, and T. Yamashita. 2004. Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J Clin Invest 113:561-568.
16. Razzaque M. S. 2009. The FGF23-Klotho axis: endocrine regulation of phosphate homeostasis. Nat Rev Endocrinol 5:611-619.
17. Prie, D. and G. Friedlander. 2010. Reciprocal control of 1,25-dihydroxyvitamin D and FGF23 formation involving the FGF23/Klotho system. Clin J Am Soc Nephrol 5:1717-1722.
18. Ohyama. Y. and T. Yamasaki. 2004. Eight cytochrome P450s catalyze vitamin D metabolism. Front Biosci 9:3007-3018.
19. Ritter, C. S., H. J. Armbrecht, E. Slatopolsky, and A. J. Brown. 2006. 25-hydroxyvitamin D(3) suppresses PTH synthesis and secretion by bovine parathyroid cells. Kidney Int 70:654-659.
20. van Driel, M., M. Koedam, C. J. Buurman, M. Hewison, H. Chiba, A. G. Uitterlinden, H. A. Pols, and J. P. van Leeuwen. 2006. Evidence for auto/paracrine actions of vitamin D in bone: 1alpha-hydroxylase expression and activity in human bone cells. FASEB J 20:2417-2419.
21. Takeyama, K., S. Kitanaka, T. Sato, M. Kobori, J. Yanagisawa, and S. Kato. 1997. 25-Hydroxyvitamin D3 1alpha-hydroxylase and vitamin D synthesis. Science 277:1827-1830.
22. Fu, G. K., D. Lin, M. Y. Zhang, D. D. Bikle, C. H. Shackleton, W. L. Miller, and A. A. Portale. 1997. Cloning of human 25-hydroxyvitamin D-1 alpha-hydroxylase and mutations causing vitamin D-dependent rickets type 1. Mol Endocrinol 11:1961-1970.
23. Zehnder, D., R. Bland, M. C. Williams, R. W. McNinch, A. J. Howie, P. M. Stewart, and M. Hewison. 2001. Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase. J Clin Endocrinol Metab 86:888-894.
24. Bikle, D. D., S. Pillai, E. Gee, and M. Hincenbergs. 1989. Regulation of 1,25-dihydroxyvitamin D production in human keratinocytes by interferon-gamma. Endocrinology 124:655-660.
25. Pillai, S., D. D. Bikle, and P. M. Elias. 1988. 1,25-Dihydroxyvitamin D production and receptor binding in human keratinocytes varies with differentiation. J Biol Chem 263:5390-5395.
26. Pillai, S., D. D. Bikle, and P. M. Elias. 1988. Vitamin D and epidermal differentiation: evidence for a role of endogenously produced vitamin D metabolites in keratinocyte differentiation. Skin Pharmacol 1:149-160.
27. Vanhooke, J. L., J. M. Prahl, C. Kimmel-Jehan, M. Mendelsohn, E. W. Danielson, K. D. Healy, and H. F. Deluca. 2006. CYP27B1 null mice with LacZreporter gene display no 25-hydroxyvitamin D3-1{alpha}-hydroxylase promoter activity in the skin. Proc Natl Acad Sci USA 103:75-80.
28. Bikle, D. D., S. Chang, D. Crumrine, H. Elalieh, M. Q. Man, O. Dardenne, Z. Xie, R. S. Arnaud, K. Feingold, and P. M. Elias. 2004. Mice lacking 25OHD 1alpha-hydroxylase demonstrate decreased epidermal differentiation and barrier function. J Steroid Biochem Mol Biol 89-90:347-353.
29. Bikle, D. D., S. Chang, D. Crumrine, H. Elalieh, M. Q. Man, E. H. Choi, O. Dardenne, Z. Xie, R. S. Arnaud, K. Feingold, and P. M. Elias. 2004. 25 Hydroxyvitamin D 1 alpha-hydroxylase is required for optimal epidermal differentiation and permeability barrier homeostasis. J Invest Dermatol 122:984-992.
30. Huang, D. C., V. Papavasiliou, J. S. Rhim, R. L. Horst, R. Kremer. 2002. Targeted disruption of the 25-hydroxyvitamin D3 1alpha-hydroxylase gene in ras-transformed keratinocytes demonstrates that locally produced 1alpha,25-dihydroxyvitamin D3 suppresses growth and induces differentiation in an autocrine fashion. Mol Cancer Res 1:56-67.
31. Flanagan, J. N., L. W. Whitlatch, T. C. Chen, X. H. Zhu, M. T. Holick, X. F. Kong, and M. F. Holick. 2001. Enhancing 1 alpha-hydroxylase activity with the 25-hydroxyvitamin D-1 alpha-hydroxylase gene in cultured human keratinocytes and mouse skin. J Invest Dermatol 116:910-914.
32. Abe, E., C. Miyaura, H. Sakagami, M. Takeda, K. Konno, T. Yamazaki, S. Yoshiki, and T. Suda. 1981. Differentiation of mouse myeloid leukemia cells induced by 1 alpha,25-dihydroxyvitamin D3. Proc Natl Acad Sci USA 78:4990-4994.
33. Abe, E., C. Miyaura, H. Tanaka, Y. Shiina, T. Kuribayashi, S. Suda, Y. Nishii, H. F. De Luca, T. Suda. 1983. 1 alpha,25-dihydroxyvitamin D3 promotes fusion of mouse alveolar macrophages both by a direct mechanism and by a spleen cell-mediated indirect mechanism. Proc Natl Acad Sci USA 80:5583-5587.
34. Tanaka, H., E. Abe, C. Miyaura, Y. Shiina, T. Suda. 1983. 1 alpha,25-dihydroxyvitamin D3 induces differentiation of human promyelocytic leukemia cells (HL-60) into monocyte-macrophages, but not into granulocytes. Biochem Biophys Res Commun 117:86-92.
35. Koeffler, H. P., T. Amatruda, N. Ikekawa, Y. Kobayashi, and H. F. De Luca 1984. Induction of macrophage differentiation of human normal and leukemic myeloid stem cells by 1,25-dihydroxyvitamin D3 and its fluorinated analogues. Cancer Res 44:5624-5628.
36. Reichel, H., H. P. Koeffler, R. Barbers, and A. W. Norman. 1987. Regulation of 1,25-dihydroxyvitamin D3 production by cultured alveolar macrophages from normal human donors and from patients with pulmonary sarcoidosis. J Clin Endocrinol Metab 65:1201-1209.
37. Reichel, H., H. P. Koeffler, J. E. Bishop, and A. W. Norman. 1987. 25-Hydroxyvitamin D3 metabolism by lipopolysaccharide-stimulated normal human macrophages. J Clin Endocrinol Metab 64:1-9.
38. Koeffler, H. P., H. Reichel, J. E. Bishop, and A. W. Norman. 1985. gamma-Interferon stimulates production of 1,25-dihydroxyvitamin D3 by normal human macrophages. Biochem Biophys Res Commun 127:596-603.
39. Kreutz, M., R. Andreesen, S. W. Krause, A. Szabo, E. Ritz, and H. Reichel. 1993. 1,25-dihydroxyvitamin D3 production and vitamin D3 receptor expression are developmentally regulated during differentiation of human monocytes into macrophages. Blood 82:1300-1307.
40. Hewison, M., S. Barker, A. Brennan, J. Nathan, D. R. Katz, and J. L. O’Riordan. 1989. Autocrine regulation of 1,25-dihydroxycholecalciferol metabolism in myelomonocytic cells. Immunology 68:247-252.
41. Liu, P. T., S. Stenger, H. Li, L. Wenzel, B. H. Tan, S. R. Krutzik, M. T. Ochoa, J. Schauber, K. Wu, C. Meinken, D. L. Kamen, M. Wagner, R. Bals, A. Steinmeyer, U. Zugel, R. L. Gallo, D. Eisenberg, M. Hewison, B. W. Hollis, J. S. Adams, B. R. Bloom, and R. L. Modlin. 2006. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311:1770-1773.
42. Adams, J. S., S. Ren, P. T. Liu, R. F. Chun, V. Lagishetty, A. F. Gombart, N. Borregaard, R. L. Modlin, and M. Hewison. 2009. Vitamin D-directed rheostatic regulation of monocyte antibacterial responses. J Immunol 182:4289-4295.
43. Liu, P. T., M. Schenk, V. P. Walker, P. W. Dempsey, M. Kanchanapoomi, M. Wheelwright, A. Vazirnia, X. Zhang, A. Steinmeyer, U. Zugel, B. W. Hollis, G. Cheng, and R. L. Modlin. 2009. Convergence of IL-1beta and VDR activation pathways in human TLR2/1-induced antimicrobial responses. PLoS One 4:e5810.
44. Wang, T. T., B. Dabbas, D. Laperriere, A. J. Bitton, H. Soualhine, L. E. Tavera-Mendoza, S. Dionne, M. J. Servant, A. Bitton, E. G. Seidman, S. Mader, M. A. Behr, and J.H. White. 2010. Direct and indirect induction by 1,25-dihydroxyvitamin D3 of the NOD2/CARD15-beta defensin 2 innate immune pathway defective in Crohn’s disease. J Biol Chem 285:2227-2231.
45. Wang, T. T., F. P. Nestel, V. Bourdeau, Y. Nagai, Q. Wang, J. Liao, L Tavera-Mendoza, R. Lin, J. W. Hanrahan, S. Mader, and J. H. White. 2004. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol 173:2909-2912.
46. Gombart, A. F., N. Borregaard, H. P. Koeffler. 2005. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25- dihydroxyvitamin D3. FASEB J 19:1067-1077.
47. Sly, L. M., M. Lopez, W. M. Nauseef, and N. E. Reiner. 2001. 1alpha,25-Dihydroxyvitamin D3-induced monocyte antimycobacterial activity is regulated by phosphatidylinositol 3-kinase and mediated by the NADPH-dependent phagocyte oxidase. J Biol Chem 276:35482-35493.
48. Kohchi, C., H. Inagawa, T. Nishizawa, and G. Soma. 2009. ROS and innate immunity. Anticancer Res 29:817-821.
49. Chan, J., Y. Xing, R. S. Magliozzo, and B. R. Bloom. 1992. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J Exp Med 175:1111-1122.
50. Sorensen, O. E., P. Follin, A. H. Johnsen, J. Calafat, G. S. Tjabringa, P. S. Hiemstra, and N. Borregaard. 2001. Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. Blood 97:3951-3959.
51. Klionsky, D. J. and S. D. Emr. 2000. Autophagy as a regulated pathway of cellular degradation. Science 290:1717-1721.
52. Gutierrez, M. G., S. S. Master, S. B. Singh, G. A. Taylor, M. I. Colombo, and V. Deretic. 2004. Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell 119:753-766.
53. Deretic, V. and B. Levine. 2009. Autophagy, immunity, and microbial adaptations. Cell Host Microbe 5:527-549.
54. Shin, D. M., J. M. Yuk, H. M. Lee, S. H. Lee, J. W. Son, C. V. Harding, J. M. Kim, R L. Modlin, and E. K. Jo. 2011. Mycobacterial Lipoprotein Activates Autophagy via TLR2/1/CD14 and a Functional Vitamin D Receptor Signaling. Cell Microbiol.
55. Brennan, A., D. R. Katz, J. D. Nunn, S. Barker, M. Hewison, L. J. Fraher, and J. L. O’Riordan. 1987. Dendritic cells from human tissues express receptors for the immunoregulatory vitamin D3 metabolite, dihydroxycholecalciferol. Immunology 61:457-461.
56. Hewison, M., L. Freeman, S. V. Hughes, K. N. Evans, R. Bland, A. G. Eliopoulos, M. D. Kilby, P. A. Moss, and R. Chakraverty. 2003. Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells. J Immunol 170:5382-5390.
57. Fritsche, J., K. Mondal, A. Ehrnsperger, R. Andreesen, and M. Kreutz. 2003. Regulation of 25-hydroxyvitamin D3-1 alpha-hydroxylase and production of 1 alpha,25-dihydroxyvitamin D3 by human dendritic cells. Blood 102:3314-3316.
58. Hewison, M., D. Zehnder, R. Chakraverty, and J. S. Adams. 2004. Vitamin D and barrier function: a novel role for extra-renal 1 alpha-hydroxylase. Mol Cell Endocrinol 215:31-38.
59. Sigmundsdottir, H., J. Pan, G. F. Debes, C. Alt, A. Habtezion, D. Soler, and E. C. Butcher. 2007. DCs metabolize sunlight-induced vitamin D3 to ‘program’ T cell attraction to the epidermal chemokine CCL27. Nat Immunol 8:285-293.
60. Chen, S., G. P. Sims, X. X. Chen, Y. Y. Gu, S. Chen, and P. E. Lipsky. 2007. Modulatory effects of 1,25-dihydroxyvitamin d3 on human B cell differentiation. J Immunol 179:1634-1647.
61. Gray, T. K., G. E. Lester, and R. S. Lorenc. 1979. Evidence for extra-renal 1 alpha-hydroxylation of 25-hydroxyvitamin D3 in pregnancy. Science 204:1311-1313.
62. Weisman, Y., A. Harell, S. Edelstein, M. David, Z. Spirer, and A. Golander. 1979. 1 alpha, 25-Dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 in vitro synthesis by human decidua and placenta. Nature 281:317-319.
63. Zehnder, D., K. N. Evans, M. D. Kilby, J. N. Bulmer, B. A. Innes, P. M. Stewart, and M. Hewison. 2002. The ontogeny of 25-hydroxyvitamin D(3) 1alpha-hydroxylase expression in human placenta and decidua. Am J Pathol 161:105-114.
64. Evans, K. N., J. N. Bulmer, M. D. Kilby, and M. Hewison. 2004. Vitamin D and placental-decidual function. J Soc Gynecol Investig 11:263-271.
65. Novakovic, B., M. Sibson, H. K. Ng, U. Manuelpillai, V. Rakyan, T. Down, S. Beck, T. Fournier, D. Evain-Brion, E. Dimitriadis, J. M. Craig, R. Morley, and R. Saffery. 2009. Placenta-specific methylation of the vitamin D 24-hydroxylase gene: implications for feedback autoregulation of active vitamin D levels at the fetomaternal interface. J Biol Chem 284:14838-14848.
66. Kovacs, C. S. and H. M. Kronenberg. 1997. Maternal-fetal calcium and bone metabolism during pregnancy, puerperium, and lactation. Endocr Rev 18:832-872.
67. Bruns, M. E. and D. E. Bruns. 1983. Vitamin D metabolism and function during pregnancy and the neonatal period. Ann Clin Lab Sci 13:521-530.
68. Rebut-Bonneton, C. and J. Demignon. 1991. Effects of 1,25-dihydroxyvitamin D3 on in vitro lymphocyte reactions: arguments for a role at the maternofetal interface. Gynecol Obstet Invest 32:134-138.
69. Sacks, G., I. Sargent, and C. Redman. 2000. Innate immunity in pregnancy. Immunol Today 21:200-201.
70. Sacks, G., I. Sargent, and C. Redman. 1999. An innate view of human pregnancy. Immunol Today 20:114-118.
71. Guleria, I. and J. W. Pollard. 2000. The trophoblast is a component of the innate immune system during pregnancy. Nat Med 6:589-593.
72. Zenclussen, A. C., A. Schumacher, M. L. Zenclussen, P. Wafula, and H. D. Volk 2007. Immunology of pregnancy: Cellular mechanisms allowing fetal survival within the maternal uterus. Expert Rev Mol Med 9:1-14.
73. Laskarin, G., U. Kammerer, D. Rukavina, A. W. Thomson, N. Fernandez, S. M. Blois. 2007. Antigen-presenting cells and materno-fetal tolerance: An emerging role for dendritic cells. Am J Reprod Immunol 58:255-267.
74. King, A. E., R. W. Kelly, J. M. Sallenave, A. D. Bocking, and J. R. Challis. 2007. Innate immune defenses in the human uterus during pregnancy. Placenta 28:1099-1106.
75. King, A. E., A. Paltoo, R. W. Kelly, J. M. Sallenave, A. D. Bocking, and J. R. Challis. 2007. Expression of natural antimicrobials by human placenta and fetal membranes. Placenta 28:161-169.
76. Svinarich, D. M., N A. Wolf, R. Gomez, B. Gonik, and R. Romero. 1997. Detection of human defensin 5 in reproductive tissues. Am J Obstet Gynecol 176:470-475.
77. Abrahams, V. M., T. M. Schaefer, J. V. Fahey, I. Visintin, J. A. Wright, P. B. Aldo, R. Romero, C. R. Wira, and G. Mor. 2006. Expression and secretion of antiviral factors by trophoblast cells following stimulation by the TLR-3 agonist, Poly(I: C). Hum Reprod 21:2432-2439.
78. Evans, K. N., L. Nguyen, J. Chan, B. A. Innes, J. N. Bulmer, M. D. Kilby, and M. Hewison. 2006. Effects of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 on cytokine production by human decidual cells. Biol Reprod 75:816-822.
79. Liu, N., A. T. Kaplan, J. Low, L. Nguyen, G. Y. Liu, O. Equils, and M. Hewison. 2009. Vitamin D induces innate antibacterial responses in human trophoblasts via an intracrine pathway. Biol Reprod 80:398-406.
80. Liu, N. Q., A. T. Kaplan, V. Lagishetty, Y. B. Ouyang, Y. Ouyang, C. F. Simmons, O. Equils, and M. Hewison. 2011. Vitamin D and the regulation of placental inflammation. J Immunol 186:5968-5974.
81. Bodnar, L. M., M. A. Krohn, and H. N. Simhan. 2009. Maternal vitamin D deficiency is associated with bacterial vaginosis in the first trimester of pregnancy. J Nutr 139:1157-1161.
82. Mehta, S., D. J. Hunter, F. M. Mugusi, D. Spiegelman, K. P. Manji, E. L. Giovannucci, E. Hertzmark, G. I. Msamanga, and W. W. Fawzi. 2009. Perinatal outcomes, including mother-to-child transmission of HIV, and child mortality and their association with maternal vitamin D status in Tanzania. J Infect Dis 200:1022-1030.
83. Al-Husaini, A. M. 2009. Role of placenta in the vertical transmission of human immunodeficiency virus. J Perinatol 29:331-336.
84. Fischer, D., A. Schroer, D. Ludders, T. Cordes, B. Bucker, J. Reichrath, and M. Friedrich. 2007. Metabolism of vitamin D3 in the placental tissue of normal and preeclampsia complicated pregnancies and premature births. Clin Exp Obstet Gynecol 34:80-84.
85. Diaz, L., C. Arranz, E. Avila, A. Halhali, F. Vilchis, and F. Larrea. 2002. Expression and activity of 25-hydroxyvitamin D-1 alpha-hydroxylase are restricted in cultures of human syncytiotrophoblast cells from preeclamptic pregnancies. J Clin Endocrinol Metab 87:3876-3882.
86. Bodnar, L. M., J. M. Catov, H. N. Simhan, M. F. Holick, R. W. Powers, and Roberts. J. M. 2007. Maternal vitamin D deficiency increases the risk of preeclampsia. J Clin Endocrinol Metab.
87. Bodnar, L. M., H. N. Simhan, R. W. Powers, M. P. Frank, E. Cooperstein, and J. M. Roberts. 2007. High prevalence of vitamin D insufficiency in black and white pregnant women residing in the northern United States and their neonates. J Nutr 137:447-452.
88. Hypponen, E. 2005. Vitamin D for the prevention of preeclampsia? A hypothesis. Nutr Rev 63:225-232.
89. Schwartz, G. G., L. W. Whitlatch, T. C. Chen, B. L. Lokeshwar, and M. F. Holick. 1998. Human prostate cells synthesize 1,25-dihydroxyvitamin D3 from 25-hydroxyvitamin D3. Cancer Epidemiol Biomarkers Prev 7:391-395.
90. Whitlatch, L. W., M. V. Young, G. G. Schwartz, J. N. Flanagan, K. L. Burnstein, B. L. Lokeshwar, E. S. Rich, M. F. Holick, and T. C. Chen. 2002. 25-Hydroxyvitamin D-1alpha-hydroxylase activity is diminished in human prostate cancer cells and is enhanced by gene transfer. J Steroid Biochem Mol Biol 81:135-140.
91. Hsu, J. Y., D. Feldman, J. E. McNeal, and D. M. Peehl. 2001. Reduced 1alpha-hydroxylase activity in human prostate cancer cells correlates with decreased susceptibility to 25-hydroxyvitamin D3-induced growth inhibition. Cancer Res 61:2852-2856.
92. Barreto, A. M., G. G. Schwartz, R. Woodruff, and S. D. Cramer. 2000. 25-Hydroxyvitamin D3, the prohormone of 1,25-dihydroxyvitamin D3, inhibits the proliferation of primary prostatic epithelial cells. Cancer Epidemiol Biomarkers Prev 9:265-270.
93. Polek, T. C. and N. L. Weigel. 2002. Vitamin D and prostate cancer. J Androl 23:9-17.
94. Townsend, K., C. M. Banwell, M. Guy, K. W. Colston, J. L. Mansi, P. M. Stewart, M. J. Campbell, and M. Hewison. 2005. Autocrine metabolism of vitamin D in normal and malignant breast tissue. Clin Cancer Res 11:3579-3586.
95. McCarthy, K., C. Laban, S. A. Bustin, W. Ogunkolade, S. Khalaf, R. Carpenter, and P. J. Jenkins. 2009. Expression of 25-hydroxyvitamin D-1-alpha-hydroxylase, and vitamin D receptor mRNA in normal and malignant breast tissue. Anticancer Res 29:155-157.
96. Segersten, U., P. K. Holm, P. Bjorklund, O. Hessman, H. Nordgren, L. Binderup, G. Akerstrom, P. Hellman, and G. Westin. 2005. 25-Hydroxyvitamin D3 1alpha-hydroxylase expression in breast cancer and use of non-1alpha-hydroxylated vitamin D analogue. Breast Cancer Res 7:R980-986.
97. Colston, K. W., L. C. Lowe, J. L. Mansi, and M. J. Campbell. 2006. Vitamin D status and breast cancer risk. Anticancer Res 26:2573-2580.
98. Kemmis, C. M. and J. Welsh. 2008. Mammary epithelial cell transformation is associated with deregulation of the vitamin D pathway. J Cell Biochem 105:980-988.
99. Rowling, M. J., C. M. Kemmis, D. A. Taffany, and J. Welsh. 2006. Megalin-mediated endocytosis of vitamin D binding protein correlates with 25-hydroxycholecalciferol actions in human mammary cells. J Nutr 136:2754-2759.
100. Nykjaer, A., D. Dragun, D. Walther, H. Vorum, C. Jacobsen, J. Herz, F. Melsen, E. I. Christensen, and T. E. Willnow. 1999. An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3. Cell 96:507-515.
101. Welsh, J. 2004. Vitamin D and breast cancer: Insights from animal models. Am J Clin Nutr 80:1721S-1724S.
102. Turner, R. T., J. E. Puzas, M. D. Forte, G. E. Lester, T. K. Gray, G. A. Howard, and D. J. Baylink. 1980. In vitro synthesis of 1 alpha,25-dihydroxycholecalciferol and 24,25-dihydroxycholecalciferol by isolated calvarial cells. Proc Natl Acad Sci USA 77:5720-5724.
103. Howard, G. A., R. T. Turner, D. J. Sherrard, and D. J. Baylink. 1981. Human bone cells in culture metabolize 25-hydroxyvitamin D3 to 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3. J Biol Chem 256:7738-7740.
104. Pols, H. A., H. P. Schilte, P. J. Nijweide, T. J. Visser, and J. C. Birkenhager. 1984. The influence of albumin on vitamin D metabolism in fetal chick osteoblast-like cells. Biochem Biophys Res Commun 125:265-272.
105. Atkins, G. J., P. H. Anderson, D. M. Findlay, K. J. Welldon, C. Vincent, A. C. Zannettino, P. D. O’Loughlin, and H. A. Morris. 2007. Metabolism of vitamin D3 in human osteoblasts: evidence for autocrine and paracrine activities of 1 alpha,25-dihydroxyvitamin D3. Bone 40:1517-1528.
106. Somjen, D., S. Katzburg, N. Stern, F. Kohen, O. Sharon, R. Limor, N. Jaccard, D. Hendel, and Y. Weisman. 2007. 25 hydroxy-vitamin D(3)-1alpha hydroxylase expression and activity in cultured human osteoblasts and their modulation by parathyroid hormone, estrogenic compounds and dihydrotestosterone. J Steroid Biochem Mol Biol 107:238-244.
107. Anderson, P. H. and G. J. Atkins. 2008. The skeleton as an intracrine organ for vitamin D metabolism. Mol Aspects Med 29:397-406.
108. St-Arnaud. R. 2008. The direct role of vitamin D on bone homeostasis. Arch Biochem Biophys 473:225-230.
109. Pedrozo, H. A., B. D. Boyan, J. Mazock, D. D. Dean, R. Gomez, and Z. Schwartz. 1999. TGFbeta1 regulates 25-hydroxyvitamin D3 1alpha- and 24-hydroxylase activity in cultured growth plate chondrocytes in a maturation-dependent manner. Calcif Tissue Int 64:50-56.
110. Weber, L., U. Hugel, J. Reichrath, H. Sieverts, O. Mehls, and G. Klaus. 2003. Cultured rat growth plate chondrocytes express low levels of 1alpha-hydroxylase. Recent Results Cancer Res 164:147-149.
111. Schauber, J., R. A. Dorschner, A. B. Coda, A. S. Buchau, P. T. Liu, D. Kiken, Y. R. Helfrich, S. Kang, H. Z. Elalieh, A. Steinmeyer, U. Zugel, D. D. Bikle, R. L. Modlin, and R. L. Gallo. 2007. Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. J Clin Invest 117:803-811.
112. St. Arnaud, R. O. Dardenne, J. Prud’homme, S. A. Hacking, and F. H. Glorieux. 2003. Conventional and tissue-specific inactivation of the 25-hydroxyvitamin D-1alpha-hydroxylase (CYP27B1). J Cell Biochem 88:245-251.
113. Naja, R. P., O. Dardenne, A. Arabian, and R. St. Arnaud. 2009. Chondrocyte-specific modulation of Cyp27b1 expression supports a role for local synthesis of 1,25-dihydroxyvitamin D3 in growth plate development. Endocrinology 150:4024-4032.
114. Powe, C. E., C. Ricciardi, A. H. Berg, D. Erdenesanaa, G. Collerone, E. Ankers, J. Wenger, S. A. Karumanchi, R. Thadhani, and I. Bhan. 2011. Vitamin D-binding protein modifies the vitamin D-bone mineral density relationship. J Bone Miner Res 26:1609-1616.
115. Segersten, U., P. Correa, M. Hewison, P. Hellman, H. Dralle, T. Carling, G. Akerstrom, and G. Westin. 2002. 25-hydroxyvitamin D(3)-1alpha-hydroxylase expression in normal and pathological parathyroid glands. J Clin Endocrinol Metab 87:2967-2972.
116. Correa, P., U. Segersten, P. Hellman, G. Akerstrom, G. Westin. 2002. Increased 25-hydroxyvitamin D3 1alpha-hydroxylase and reduced 25-hydroxyvitamin D3 24-hydroxylase expression in parathyroid tumors-new prospects for treatment of hyperparathyroidism with vitamin D. J Clin Endocrinol Metab 87:5826-5829.
117. Kawahara, M., Y. Iwasaki, K. Sakaguchi, T. Taguchi, M. Nishiyama, T. Nigawara, M. Tsugita, M. Kambayashi, T. Suda, and K. Hashimoto. 2008. Predominant role of 25OHD in the negative regulation of PTH expression: clinical relevance for hypovitaminosis D. Life Sci 82:677-683.
118. Lauter, K. and A. Arnold. 2009. Analysis of CYP27B1, encoding 25-hydroxyvitamin D-1alpha-hydroxylase, as a candidate tumor suppressor gene in primary and severe secondary/tertiary hyperparathyroidism. J Bone Miner Res 24:102-104.
119. Krajisnik, T., P. Bjorklund, R. Marsell, O. Ljunggren, G. Akerstrom, K. B. Jonsson, G. Westin, and T. E. Larsson. 2007. Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells. J Endocrinol 195:125-131.
120. Bland, R., D. Markovic, C. E. Hills, S. V. Hughes, S. L. Chan, P. E. Squires, and M. Hewison. 2004. Expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in pancreatic islets. J Steroid Biochem Mol Biol 89-90:121-125.
121. Leung, P. S. and Q. Cheng. 2010. The novel roles of glucagon-like peptide-1, angiotensin II, and vitamin D in islet function. Adv Exp Med Biol 654:339-361.
122. Mathieu, C., C. Gysemans, A. Giulietti, and R. Bouillon. 2005. Vitamin D and diabetes. Diabetologia 48:1247-1257.
123. Khadzkou, K., P. Buchwald, G. Westin, H. Dralle, G. Akerstrom, and P. Hellman. 2006. 25-hydroxyvitamin D3 1alpha-hydroxylase and vitamin D receptor expression in papillary thyroid carcinoma. J Histochem Cytochem 54:355-361.
124. Blomberg Jensen, M., J. E. Nielsen, A. Jorgensen, E. Rajpert De Meyts, D. M. Kristensen, N. Jorgensen, N. E. Skakkebaek, A. Juul, and H. Leffers. 2010. Vitamin D receptor and vitamin D metabolizing enzymes are expressed in the human male reproductive tract. Hum Reprod 25:1303-1311.
125. Kinuta, K., H. Tanaka, T. Moriwake, K. Aya, S. Kato, and Y. Seino. 2000. Vitamin D is an important factor in estrogen biosynthesis of both female and male gonads. Endocrinology 141:1317-1324.
126. Hughes, S. V., E. Robinson, R. Bland, H. M. Lewis, P. M. Stewart, and M. Hewison. 1997. 1,25- dihydroxyvitamin D3 regulates estrogen metabolism in cultured keratinocytes. Endocrinology 138:3711-3718.
127. Fischer, D., M. Thome, S. Becker, T. Cordes, K. Diedrich, M. Friedrich, and M. Thill. 2009. Expression of 25-hydroxyvitamin D3-24-hydroxylase in benign and malignant ovarian cell lines and tissue. Anticancer Res 29:3635-3639.
128. Evans, K. N., H. Taylor, D. Zehnder, M. D. Kilby, J. N. Bulmer, F. Shah, J. S. Adams, and M. Hewison. 2004. Increased expression of 25-hydroxyvitamin D-1alpha-hydroxylase in dysgerminomas: A novel form of humoral hypercalcemia of malignancy. Am J Pathol 165:807-813.
129. Friedrich, M., L. Rafi, T. Mitschele, W. Tilgen, W. Schmidt, and J. Reichrath. 2003. Analysis of the vitamin D system in cervical carcinomas, breast cancer and ovarian cancer. Recent Results Cancer Res 164:239-246.
130. Agic, A., H. Xu, C. Altgassen, F. Noack, M. M. Wolfler, K. Diedrich, M. Friedrich, R. N. Taylor, and D. Hornung. 2007. Relative expression of 1,25-dihydroxyvitamin D3 receptor, vitamin D 1 alpha-hydroxylase, vitamin D 24-hydroxylase, and vitamin D 25-hydroxylase in endometriosis and gynecologic cancers. Reprod Sci 14:486-497.
131. Bareis, P., E. Kallay, M. G. Bischof, G. Bises, H. Hofer, C. Potzi, T. Manhardt, R. Bland, H. S. Cross. 2002. Clonal differences in expression of 25-hydroxyvitamin D(3)-1alpha-hydroxylase, of 25-hydroxyvitamin D(3)-24-hydroxylase, and of the vitamin D receptor in human colon carcinoma cells: Effects of epidermal growth factor and 1alpha,25-dihydroxyvitamin D(3). Exp Cell Res 276:320-327.
132. Bischof, M. G., M. L. Siu-Caldera, A. Weiskopf, P. Vouros, H. S. Cross, M. Peterlik, and G. S. Reddy. 1998. Differentiation-related pathways of 1 alpha,25-dihydroxycholecalciferol metabolism in human colon adenocarcinoma-derived Caco-2 cells: Production of 1 alpha,25-dihydroxy-3epi-cholecalciferol. Exp Cell Res 241:194-201.
133. Lagishetty, V., R. F. Chun, N. Q. Liu, T. S. Lisse, J. S. Adams, and M. Hewison. 1alpha-Hydroxylase and innate immune responses to 25-hydroxyvitamin D in colonic cell lines. J Steroid Biochem Mol Biol.
134. Bareis, P., G. Bises, M. G. Bischof, H. S. Cross, and M. Peterlik. 2001. 25-hydroxy-vitamin D metabolism in human colon cancer cells during tumor progression. Biochem Biophys Res Commun 285:1012-1017.
135. Kallay, E., G. Bises, E. Bajna, C. Bieglmayer, W. Gerdenitsch, I. Steffan, S. Kato, H. J. Armbrecht, and H. S. Cross. 2005. Colon-specific regulation of vitamin D hydroxylases-A possible approach for tumor prevention. Carcinogenesis 26:1581-1589.
136. Cross, H. S., G. Bises, D. Lechner, T. Manhardt, and E. Kallay. 2005. The Vitamin D endocrine system of the gut: Its possible role in colorectal cancer prevention. J Steroid Biochem Mol Biol 97:121-128.
137. Peterlik, M. and H. S. Cross. 2006. Dysfunction of the vitamin D endocrine system as common cause for multiple malignant and other chronic diseases. Anticancer Res 26:2581-2588.
138. Liu, N., L. Nguyen, R. F. Chun, V. Lagishetty, S. Ren, S. Wu, B. Hollis, H. F. De Luca, J. S. Adams, and M. Hewison. 2008. Altered endocrine and autocrine metabolism of vitamin d in a mouse model of gastrointestinal inflammation. Endocrinology 149:4799-4808.
139. Abreu, M. T., V. Kantorovich, E. A. Vasiliauskas, U. Gruntmanis, R. Matuk, K. Daigle, S. Chen, D. Zehnder, Y. C. Lin, H. Yang, M. Hewison, and J. S. Adams. 2004. Measurement of vitamin D levels in inflammatory bowel disease patients reveals a subset of Crohn’s disease patients with elevated 1,25- dihydroxyvitamin D and low bone mineral density. Gut 53:1129-1136.
140. Lagishetty, V., A. V. Misharin, N. Q. Liu, T. S. Lisse, R. F. Chun, Y. Ouyang, S. M. McLachlan, J. S. Adams, and M. Hewison. 2010. Vitamin D deficiency in mice impairs colonic antibacterial activity and predisposes to colitis. Endocrinology 151:2423-2432.
141. Hooper, L. V., T. S. Stappenbeck, C. V. Hong, and J. I. Gordon. 2003. Angiogenins: A new class of microbicidal proteins involved in innate immunity. Nat Immunol 4:269-273.
142. Packey, C. D. and R. B. Sartor. 2009. Commensal bacteria, traditional and opportunistic pathogens, dysbiosis and bacterial killing in inflammatory bowel diseases. Curr Opin Infect Dis 22:292-301.
143. Smith, S. J., A. K. Rucka, J. L. Berry, M. Davies, S. Mylchreest, C. R. Paterson, D. A. Heath, M. Tassabehji, A. P. Read, A. P. Mee, and E. B. Mawer. 1999. Novel mutations in the 1alpha-hydroxylase (P450c1) gene in three families with pseudovitamin D-deficiency rickets resulting in loss of functional enzyme activity in blood-derived macrophages. J Bone Miner Res 14:730-739.
144. Shany, S., S. Y. Ren, J. E. Arbelle, T. L. Clemens, and J. S. Adams. 1993. Subcellular localization and partial purification of the 25-hydroxyvitamin D3 1-hydroxylation reaction in the chick myelomonocytic cell line HD-11. J Bone Miner Res 8:269-276.
145. Reichel, H., H. P. Koeffler, A. W. Norman. 1987. Synthesis in vitro of 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 by interferon-gamma-stimulated normal human bone marrow and alveolar macrophages. J Biol Chem 262:10931-10937.
146. Fraser, D. R. 1980. Regulation of the metabolism of vitamin D. Physiol Rev 60:551-613.
147. Adams, J. S., S. Y. Ren, J. E. Arbelle, N. Horiuchi, R. W. Gray, T. L. Clemens, and S. Shany. 1994. Regulated production and intracrine action of 1,25-dihydroxyvitamin D3 in the chick myelomonocytic cell line HD-11. Endocrinology 134:2567-2573.
148. Nakamura, Y., T. A. Eto, T. Taniguchi, K. Miyamoto, J. Nagatomo, H. Shiotsuki, H. Sueta, S. Higashi, K. I. Okuda, and T. Setoguchi. 1997. Purification and characterization of 25-hydroxyvitamin D3 1alpha-hydroxylase from rat kidney mitochondria. FEBS Lett 419:45-48.
149. Inouye, K. and Sakaki, T. 2001. Enzymatic studies on the key enzymes of vitamin D metabolism; 1 alpha-hydroxylase (CYP27B1) and 24-hydroxylase (CYP24). Biotechnol Annu Rev 7:179-194.
150. Hakeda, Y., K. Hiura, T. Sato, R. Okazaki, T. Matsumoto, E. Ogata, R. Ishitani, and M. Kumegawa. 1989. Existence of parathyroid hormone binding sites on murine hemopoietic blast cells. Biochem Biophys Res Commun 163:1481-1486.
151. Bland, R., E. A. Walker, S. V. Hughes, P. M. Stewart, and M. Hewison. 1999. Constitutive expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in a transformed human proximal tubule cell line: evidence for direct regulation of vitamin D metabolism by calcium. Endocrinology 140:2027-2034.
152. Yuan, J. Y., A. J. Freemont, E. B. Mawer, and M. E. Hayes. 1992. Regulation of 1 alpha, 25-dihydroxyvitamin D3 synthesis in macrophages from arthritic joints by phorbol ester, dibutyryl-cAMP and calcium ionophore (A23187). FEBS Lett 311:71-74.
153. Henry, H. L. 1981. 25(OH)D3 metabolism in kidney cell cultures: lack of a direct effect of estradiol. Am J Physiol 240:E119-E124.
154. Adams, N. D., T. L. Garthwaite, R. W. Gray, T. C. Hagen, and J. Lemann Jr. 1979. The interrelationships among prolactin, 1,25-dihydroxyvitamin D, and parathyroid hormone in humans. J Clin Endocrinol Metab 49:628-630.
155. Brixen, K., H. K. Nielsen, R. Bouillon, A. Flyvbjerg, and L. Mosekilde. 1992. Effects of short-term growth hormone treatment on PTH, calcitriol, thyroid hormones, insulin and glucagon. Acta Endocrinol (Copenh) 127:331-336.
156. Henry, H. L. 1992. Vitamin D hydroxylases. J Cell Biochem 49:4-9.
157. Omdahl, J. L., H. A. Morris, and B. K. May. 2002. Hydroxylase enzymes of the vitamin D pathway: expression, function, and regulation. Annu Rev Nutr 22:139-166.
158. Omdahl, J. L., E. A. Bobrovnikova, S. Choe, P. P. Dwivedi, and B. K. May. 2001. Overview of regulatory cytochrome P450 enzymes of the vitamin D pathway. Steroids 66:381-389.
159. Ohyama, Y., M. Noshiro, and K. Okuda. 1991. Cloning and expression of cDNA encoding 25-hydroxyvitamin D3 24-hydroxylase. FEBS Lett 278:195-198.
160. Chen, K. S., J. M. Prahl, and H. F. De Luca. 1993. Isolation and expression of human 1,25-dihydroxyvitamin D3 24-hydroxylase cDNA. Proc Natl Acad Sci USA 90:4543-4547.
161. Zierold, C., J. A. Mings, and H. F. De Luca. 2003. Regulation of 25-hydroxyvitamin D3-24-hydroxylase mRNA by 1,25-dihydroxyvitamin D3 and parathyroid hormone. J Cell Biochem 88:234-237.
162. Henry, H. L. 1979. Regulation of the hydroxylation of 25-hydroxyvitamin D3 in vivo and in primary cultures of chick kidney cells. J Biol Chem 254:2722-2729.
163. Ebert, R., N. Schutze, J. Adamski, and F. Jakob. 2006. Vitamin D signaling is modulated on multiple levels in health and disease. Mol Cell Endocrinol 248:149-159.
164. Edfeldt, K., P. T. Liu, R. Chun, M. Fabri, M. Schenk, M. Wheelwright, C. Keegan, S. R. Krutzik, J. S. Adams, M. Hewison, and R. L. Modlin. 2010. T-cell cytokines differentially control human monocyte antimicrobial responses by regulating vitamin D metabolism. Proc Natl Acad Sci USA 107:22593-22598.
165. Xie, Z., S. J. Munson, N. Huang, A. A. Portale, W. L. Miller, and D. D. Bikle. 2002. The mechanism of 1,25-dihydroxyvitamin D(3) autoregulation in keratinocytes. J Biol Chem 277:36987-36990.
166. Ren, S., L. Nguyen, S. Wu, C. Encinas, J. S. Adams, and M. Hewison. 2005. Alternative splicing of vitamin D-24-hydroxylase: a novel mechanism for the regulation of extrarenal 1,25-dihydroxyvitamin D synthesis. J Biol Chem 280:20604-20611.
167. Adams, J. S., H. Chen, R. Chun, S. Ren, S. Wu, M. Gacad, L. Nguyen, J. Ride, P. Liu, R. Modlin, and M. Hewison. 2007. Substrate and enzyme trafficking as a means of regulating 1,25-dihydroxyvitamin D synthesis and action: the human innate immune response. J Bone Miner Res 22(Suppl 2):V20-V24.
168. Hewison, M., F. Burke, K. N. Evans, D. A. Lammas, D. M. Sansom, P. Liu, R. L. Modlin, and J. S. Adams. 2007. Extra-renal 25-hydroxyvitamin D3-1alpha-hydroxylase in human health and disease. J Steroid Biochem Mol Biol 103:316-321.
169. Krutzik, S. R., M. Hewison, P. T. Liu, J. A. Robles, S. Stenger, J. S. Adams, and R. L. Modlin. 2008. IL-15 links TLR2/1-induced macrophage differentiation to the vitamin D-dependent antimicrobial pathway. J Immunol 181:7115-7120.
170. Waldmann, T. A. 2006. The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design. Nat Rev Immunol 6:595-601.
171. Schoenborn, J. R. and C. B. Wilson. 2007. Regulation of interferon-gamma during innate and adaptive immune responses. Adv Immunol 96:41-101.
172. Josien, R., B. R. Wong, H. L. Li, R. M. Steinman, and Y. Choi. 1999. TRANCE, a TNF family member, is differentially expressed on T cell subsets and induces cytokine production in dendritic cells. J Immunol 162:2562-2568.
173. Murayama, A., K. Takeyama, S. Kitanaka, Y. Kodera, T. Hosoya, and S. Kato. 1998. The promoter of the human 25-hydroxyvitamin D3 1 alpha-hydroxylase gene confers positive and negative responsiveness to PTH, calcitonin, and 1 alpha,25(OH)2D3. Biochem Biophys Res Commun 249:11-16.
174. Kong, X. F., X. H. Zhu, Y. L. Pei, D. M. Jackson, and M. F. Holick. 1999. Molecular cloning, characterization, and promoter analysis of the human 25-hydroxyvitamin D3-1alpha-hydroxylase gene. Proc Natl Acad Sci USA 96:6988-6993.
175. Platanias, L. C. and E. N. Fish. 1999. Signaling pathways activated by interferons. Exp Hematol 27:1583-1592.
176. Imada, K. and W. J. Leonard. 2000. The Jak-STAT pathway. Mol Immunol 37:1-11.
177. Ishihara, K. and T. Hirano. 2002. Molecular basis of the cell specificity of cytokine action. Biochim Biophys Acta 1592:281-296.
178. Xaus, J., M. Comalada, A. F. Valledor, M. Cardo, C. Herrero, C. Soler, J. Lloberas, and A. Celada. 2001. Molecular mechanisms involved in macrophage survival, proliferation, activation or apoptosis. Immunobiology 204:543-550.
179. Stoffels, K., L. Overbergh, A. Giulietti, L. Verlinden, R. Bouillon, and C. Mathieu. 2006. Immune regulation of 25-hydroxyvitamin-d(3)-1alpha-hydroxylase in human monocytes. J Bone Miner Res 21:37-47.
180. Stoffels, K., L. Overbergh, A. Giulietti, L. Verlinden, R. Bouillon, and C. Mathieu. 2006. Immune regulation of 25-hydroxyvitamin-D3-1alpha-hydroxylase in human monocytes. J Bone Miner Res 21:37-47.
181. Stoffels, K., L. Overbergh, R. Bouillon, and C. Mathieu. 2007. Immune regulation of 1alpha-hydroxylase in murine peritoneal macrophages: Unraveling the IFNgamma pathway. J Steroid Biochem Mol Biol 103:567-571.
182. Medzhitov, R. and C. Janeway Jr. 2000. The Toll receptor family and microbial recognition. Trends Microbiol 8:452-456.
183. Trinchieri, G. and A. Sher. 2007. Cooperation of Toll-like receptor signals in innate immune defence. Nat Rev Immunol 7:179-190.
184. Adams, J. S., S. Y. Ren, J. E. Arbelle, T. L. Clemens, and S. Shany. 1994. A role for nitric oxide in the regulated expression of the 25-hydroxy-vitamin D-1-hydroxylation reaction in the chick myelomonocytic cell line HD-11. Endocrinology 134:499-502.
185. Adams, J. S., S. Y. Ren, J. E. Arbelle, S. Shany, and M. A. Gacad. 1995. Coordinate regulation of nitric oxide and 1,25-dihydroxyvitamin D production in the avian myelomonocytic cell line HD-11. Endocrinology 136:2262-2269.
186. Adams, J. S. and S. Y. Ren. 1996. Autoregulation of 1,25-dihydroxyvitamin D synthesis in macrophage mitochondria by nitric oxide. Endocrinology 137:4514-4517.
187. Nathan, C. and Q. W. Xie. 1994. Nitric oxide synthases: roles, tolls, and controls. Cell 78:915-918.
188. Salkowski, C. A., G. Detore, R. McNally, N. van Rooijen, and S. N. Vogel. 1997. Regulation of inducible nitric oxide synthase messenger RNA expression and nitric oxide production by lipopolysaccharide in vivo: the roles of macrophages, endogenous IFN-gamma, and TNF receptor-1-mediated signaling. J Immunol 158:905-912.
189. Alley, E. W., W. J. Murphy, and S. W. Russell. 1995. A classical enhancer element responsive to both lipopolysaccharide and interferon-gamma augments induction of the iNOS gene in mouse macrophages. Gene 158:247-251.
190. Khatsenko, O. G., S. S. Gross, A. B. Rifkind, and J. R. Vane. 1993. Nitric oxide is a mediator of the decrease in cytochrome P450-dependent metabolism caused by immunostimulants. Proc Natl Acad Sci USA 90:11147-11151.
191. Stadler, J., J. Trockfeld, W. A. Schmalix, T. Brill, J. R. Siewert, H. Greim, and J. Doehmer. 1994. Inhibition of cytochromes P4501A by nitric oxide. Proc Natl Acad Sci USA 91:3559-3563.
192. Enioutina, E. Y., D. Bareyan, and R. A. Daynes. 2008. TLR ligands that stimulate the metabolism of vitamin D3 in activated murine dendritic cells can function as effective mucosal adjuvants to subcutaneously administered vaccines. Vaccine 26:601-613.
193. Enioutina, E. Y., D. Bareyan, and R. A. Daynes. 2009. TLR-induced local metabolism of vitamin D3 plays an important role in the diversification of adaptive immune responses. J Immunol 182:4296-4305.
194. Takeda, K. and S. Akira. 2005. Toll-like receptors in innate immunity. Int Immunol 17:1-14.
195. Casella, C. R. and T. C. Mitchell. 2008. Putting endotoxin to work for us: Monophosphoryl lipid A as a safe and effective vaccine adjuvant. Cell Mol Life Sci 65:3231-3240.
196. Mata-Haro, V., C. Cekic, M. Martin, P. M. Chilton, C. R. Casella, and T. C. Mitchell. 2007. The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4. Science 316:1628-1632.
197. Kallas, M., F. Green, M. Hewison, C. White, and G. Kline. 2010. Rare causes of calcitriol-mediated hypercalcemia: a case report and literature review. J Clin Endocrinol Metab 95:3111-3117.
198. Harrell, G. T. and S. Fisher. 1939. Blood chemical changes in Boeck’s sarcoid with particular reference to protein, calcium and phosphatase values. J Clin Invest 18:687-693.
199. Albright, F., E. L. Carroll, E. F. Dempsey, and P. H. Henneman. 1956. The cause of hypercalcuria in sarcoid and its treatment with cortisone and sodium phytate. J Clin Invest 35:1229-1242.
200. Taylor, R. L., H. J. Lynch Jr., W. G. Wysor Jr. 1963. Seasonal influence of sunlight on the hypercalcemia of sarcoidosis. Am J Med 34:221-227.
201. Dent, C. E., F. V. Flynn, and J. D. Nabarro. 1953. Hypercalcaemia and impairment of renal function in generalized sarcoidosis. Br Med J 2:808-810.
202. Bell, N. H. G. J. J. and F. C. Barter. 1964. Abnormal calcium absorption in sarcoidosis: evidence for increased sensitivity to vitamin D. Am J Med 36:500-513.
203. Holick, M. F. 1990. The use and interpretation of assays for vitamin D and its metabolites. J Nutr 120(Suppl 11):1464-1469.
204. Bell, N. H., P. H. Stern, E. Pantzer, T. K. Sinha, and H. F. De Luca. 1979. Evidence that increased circulating 1 alpha, 25-dihydroxyvitamin D is the probable cause for abnormal calcium metabolism in sarcoidosis. J Clin Invest 64:218-225.
205. Papapoulos, S. E., T. L. Clemens, L. J. Fraher, I. G. Lewin, L. M. Sandler, and J. L. O’Riordan. 1979. 1, 25-dihydroxycholecalciferol in the pathogenesis of the hypercalcaemia of sarcoidosis. Lancet 1:627-630.
206. Stern, P. H., J. De Olazabal, and N. H. Bell. 1980. Evidence for abnormal regulation of circulating 1 alpha,25-dihydroxyvitamin D in patients with sarcoidosis and normal calcium metabolism. J Clin Invest 66:852-855.
207. Barbour, G. L., J. W. Coburn, E. Slatopolsky, A. W. Norman, and R. L. Horst. 1981. Hypercalcemia in an anephric patient with sarcoidosis: evidence for extrarenal generation of 1,25-dihydroxyvitamin D. N Engl J Med 305:440-443.
208. Adams, J. S., O. P. Sharma, M. A. Gacad, and F. R. Singer. 1983. Metabolism of 25-hydroxyvitamin D3 by cultured pulmonary alveolar macrophages in sarcoidosis. J Clin Invest 72:1856-1860.
209. Adams, J. S. and M. A. Gacad. 1985. Characterization of 1 alpha-hydroxylation of vitamin D3 sterols by cultured alveolar macrophages from patients with sarcoidosis. J Exp Med 161:755-765.
210. Adams, J. S., F. R. Singer, M. A. Gacad, O. P. Sharma, M. J. Hayes, P. Vouros, and M. F. Holick. 1985. Isolation and structural identification of 1,25-dihydroxyvitamin D3 produced by cultured alveolar macrophages in sarcoidosis. J Clin Endocrinol Metab 60:960-966.
211. Bell, N. H. 1991. Endocrine complications of sarcoidosis. Endocrinol Metab Clin North Am 20:645-654.
212. Basile, J. N., Y. Liel, J. Shary, and N. H. Bell. 1993. Increased calcium intake does not suppress circulating 1,25-dihydroxyvitamin D in normocalcemic patients with sarcoidosis. J Clin Invest 91:1396-1398.
213. Sandler, L. M., C. G. Winearls, L. J. Fraher, T. L. Clemens, R. Smith, and J. L. O’Riordan. 1984. Studies of the hypercalcaemia of sarcoidosis: effect of steroids and exogenous vitamin D3 on the circulating concentrations of 1,25-dihydroxy vitamin D3. Q J Med 53:165-180.
214. Cronin, C. C., S. F. Dinneen, M. S. O’Mahony, C. P. Bredin, and D. J. O’Sullivan. 1990. Precipitation of hypercalcaemia in sarcoidosis by foreign sun holidays: report of four cases. Postgrad Med J 66:307-309.
215. Insogna, K. L., B. E. Dreyer, M. Mitnick, A. F. Ellison, and A. E. Broadus. 1988. Enhanced production rate of 1,25-dihydroxyvitamin D in sarcoidosis. J Clin Endocrinol Metab 66:72-75.
216. Shulman, L. E., E. H. Schoenrich, and A. M. Harvey. 1952. The effects of adrenocorticotropic hormone (ACTH) and cortisone on sarcoidosis. Bull Johns Hopkins Hosp 91:371-415.
217. Anderson, J., C. Harper, C. E. Dent, and G. R. Philpot. 1954. Effect of cortisone on calcium metabolism in sarcoidosis with hypercalcaemia, possibly antagonistic actions of cortisone and vitamin D. Lancet 267:720-724.
218. O’Leary, T. J., G. Jones, A. Yip, D. Lohnes, M. Cohanim, and E. R. Yendt. 1986. The effects of chloroquine on serum 1,25-dihydroxyvitamin D and calcium metabolism in sarcoidosis. N Engl J Med 315:727-730.
219. Barre, P. E., M. Gascon-Barre, J. L. Meakins, and D. Goltzman. 1987. Hydroxychloroquine treatment of hypercalcemia in a patient with sarcoidosis undergoing hemodialysis. Am J Med 82:1259-1262.
220. Adams. J. S., O. P. Sharma, M. M. Diz, and D. B. Endres. 1990. Ketoconazole decreases the serum 1,25-dihydroxyvitamin D and calcium concentration in sarcoidosis-associated hypercalcemia. J Clin Endocrinol Metab 70:1090-1095.
221. Adams, J. S., M. M., and O. P. Sharma. 1989. Effective reduction in the serum 1,25-dihydroxyvitamin D and calcium concentration in sarcoidosis-associated hypercalcemia with short-course chloroquine therapy. Ann Intern Med 111:437-438.
222. Felsenfeld, A. J., M. K. Drezner, and F. Llach. 1986. Hypercalcemia and elevated calcitriol in a maintenance dialysis patient with tuberculosis. Arch Intern Med 146:1941-1945.
223. Gkonos, P. J., R. London, and E. D. Hendler. 1984. Hypercalcemia and elevated 1,25-dihydroxyvitamin D levels in a patient with end-stage renal disease and active tuberculosis. N Engl J Med 311:1683-1685.
224. Epstein, S., P. H. Stern, N. H. Bell, I. Dowdeswell, and R. T. Turner. 1984. Evidence for abnormal regulation of circulating 1 alpha, 25-dihydroxyvitamin D in patients with pulmonary tuberculosis and normal calcium metabolism. Calcif Tissue Int 36:541-544.
225. Bell, N. H., J. Shary, S. Shaw, and R. T. Turner. 1985. Hypercalcemia associated with increased circulating 1,25 dihydroxyvitamin D in a patient with pulmonary tuberculosis. Calcif Tissue Int 37:588-591.
226. Cadranel, J., M. Garabedian, B. Milleron, H. Guillozo, G. Akoun, and A. J. Hance. 1990. 1,25(OH)2D2 production by T lymphocytes and alveolar macrophages recovered by lavage from normocalcemic patients with tuberculosis. J Clin Invest 85:1588-1593.
227. Cadranel, J. L., M. Garabedian, B. Milleron, H. Guillozzo, D. Valeyre, F. Paillard, G. Akoun, and A. J. Hance. 1994. Vitamin D metabolism by alveolar immune cells in tuberculosis: correlation with calcium metabolism and clinical manifestations. Eur Respir J 7:1103-1110.
228. Isaacs, R. D., G. I. Nicholson, and I. M. Holdaway. 1987. Miliary tuberculosis with hypercalcaemia and raised vitamin D concentrations. Thorax 42:555-556.
229. Shai, F., R. K. Baker, J. R. Addrizzo, and S. Wallach. 1972. Hypercalcemia in mycobacterial infection. J Clin Endocrinol Metab 34:251-256.
230. Braman, S. S., A. L. Goldman, and M. I. Schwarz. 1973. Steroid-responsive hypercalcemia in disseminated bone tuberculosis. Arch Intern Med 132:269-271.
231. Need, A. G., P. J. Phillips, F. Chiu, and H. Prisk. 1980. Hypercalcaemia associated with tuberculosis. Br Med J 280:831.
232. Hoffman, V. N. and O. M. Korzeniowski. 1986. Leprosy, hypercalcemia, and elevated serum calcitriol levels. Ann Intern Med 105:890-891.
233. Ryzen, E., T. H. Rea, and F. R. Singer. 1988. Hypercalcemia and abnormal 1,25-dihydroxyvitamin D concentrations in leprosy. Am J Med 84:325-329.
234. Kantarjian, H. M., M. F. Saad, E. H. Estey, R. V. Sellin, and N. A. Samaan. 1983. Hypercalcemia in disseminated candidiasis. Am J Med 74:721-724.
235. Spindel, S. J., R. J. Hamill, P. R. Georghiou, C. E. Lacke, L. K. Green, and L. E. Mallette. 1995. Case report: Vitamin D-mediated hypercalcemia in fungal infections. Am J Med Sci 310:71-76.
236. Murray, J. J. and C. R. Heim. 1985. Hypercalcemia in disseminated histoplasmosis. Aggravation by vitamin D. Am J Med 78:881-884.
237. Walker, J. V., D. Baran, N. Yakub, and R. B. Freeman. 1977. Histoplasmosis with hypercalcemia, renal failure, and papillary necrosis: Confusion with sarcoidosis. JAMA 237:1350-1352.
238. Parker, M. S., S. Dokoh, J. M. Woolfenden, and H. W. Buchsbaum. 1984. Hypercalcemia in coccidioidomycosis. Am J Med 76:341-344.
239. Kozeny, G. A., A. L. Barbato, V. K. Bansal, L. L. Vertuno, and J. E. Hano. 1984. Hypercalcemia associated with silicone-induced granulomas. N Engl J Med 311:1103-1105.
240. Jurney, T. H. 1984. Hypercalcemia in a patient with eosinophilic granuloma. Am J Med 76:527-528.
241. Edelson, G. W., G. B. Talpos, and H. G. Bone 3rd. 1993. Hypercalcemia associated with Wegener’s granulomatosis and hyperparathyroidism: Etiology and management. Am J Nephrol 13:275-277.
242. Al-Ali H., A. A. Yabis, E. Issa, Z. Salem, A. Tawil, N. Khoury, and H. Fuleihan Gel. 2002. Hypercalcemia in Langerhans’ cell granulomatosis with elevated 1,25 dihydroxyvitamin D (calcitriol) level. Bone 30:331-334.
243. Cook, J. S., M. S. Stone, and J. R. Hansen. 1992. Hypercalcemia in association with subcutaneous fat necrosis of the newborn: Studies of calcium-regulating hormones. Pediatrics 90:93-96.
244. Farooque, A., C. Moss, D. Zehnder, M. Hewison, and N. J. Shaw. 2009. Expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in subcutaneous fat necrosis. Br J Dermatol 160:423-425.
245. Bosch, X. 1998. Hypercalcemia due to endogenous overproduction of 1,25-dihydroxyvitamin D in Crohn’s disease. Gastroenterology 114:1061-1065.
246. Tuohy, K. A. and T. I. Steinman. 2005. Hypercalcemia due to excess 1,25-dihydroxyvitamin D in Crohn’s disease. Am J Kidney Dis 45:e3-e6.
247. Jahnsen, J., J. A. Falch, P. Mowinckel, and E. Aadland. 2002. Vitamin D status, parathyroid hormone and bone mineral density in patients with inflammatory bowel disease. Scand J Gastroenterol 37:192-199.
248. Tangpricha, V., J. N. Flanagan, L. W. Whitlatch, C. C. Tseng, T. C. Chen, P. R. Holt, M. S. Lipkin, and M. F. Holick. 2001. 25-hydroxyvitamin D-1alpha-hydroxylase in normal and malignant colon tissue. Lancet 357:1673-1674.
249. Zaloga, G. P., C. Eil, and C. A. Medbery. 1985. Humoral hypercalcemia in Hodgkin’s disease. Association with elevated 1,25-dihydroxycholecalciferol levels and subperiosteal bone resorption. Arch Intern Med 145:155-157.
250. Rosenthal, N., K. L. Insogna, J. W. Godsall, L. Smaldone, J. A. Waldron, and A. F. Stewart. 1985. Elevations in circulating 1,25-dihydroxyvitamin D in three patients with lymphoma-associated hypercalcemia. J Clin Endocrinol Metab 60:29-33.
251. Davies, M., E. B. Mawer, M. E. Hayes, and G. A. Lumb. 1985. Abnormal vitamin D metabolism in Hodgkin’s lymphoma. Lancet 1:1186-1188.
252. Adams, J. S., M. Fernandez, M. A. Gacad, P. S. Gill, D. B. Endres, S. Rasheed, and F. R. Singer. 1989. Vitamin D metabolite-mediated hypercalcemia and hypercalciuria patients with AIDS- and non-AIDS-associated lymphoma. Blood 73:235-239.
253. Seymour, J. F., R. F. Gagel, F. B. Hagemeister, M. A. Dimopoulos, and F. Cabanillas. 1994. Calcitriol production in hypercalcemic and normocalcemic patients with non-Hodgkin lymphoma. Ann Intern Med 121:633-640.
254. Seymour, J. F. and R. F. Gagel. 1993. Calcitriol: The major humoral mediator of hypercalcemia in Hodgkin’s disease and non-Hodgkin’s lymphomas. Blood 82:1383-1394.
255. Davies, M., M. E. Hayes, J. A. Yin, J. L. Berry, and E. B. Mawer. 1994. Abnormal synthesis of 1,25-dihydroxyvitamin D in patients with malignant lymphoma. J Clin Endocrinol Metab 78:1202-1207.
256. Hewison, M., V. Kantorovich, H. R. Liker, A. J. Van Herle, P. Cohan, D. Zehnder, and J. S. Adams. 2003. Vitamin D-mediated hypercalcemia in lymphoma: evidence for hormone production by tumor-adjacent macrophages. J Bone Miner Res 18:579-582.
257. Gates, S., J. Shary, R. T. Turner, S. Wallach, and N. H. Bell. 1986. Abnormal calcium metabolism caused by increased circulating 1,25-dihydroxyvitamin D in a patient with rheumatoid arthritis. J Bone Miner Res 1:221-226.
258. Kroger, H., I. M. Penttila, and E. M. Alhava. 1993. Low-serum vitamin D metabolites in women with rheumatoid arthritis. Scand J Rheumatol 22:172-177.
259. Oelzner, P., A. Muller, F. Deschner, M. Huller, K. Abendroth, G. Hein, and G. Stein. 1998. Relationship between disease activity and serum levels of vitamin D metabolites and PTH in rheumatoid arthritis. Calcif Tissue Int 62:193-198.
260. Muller, K., N. J. Kriegbaum, B. Baslund, O. H. Sorensen, M. Thymann, and K. Bentzen. 1995. Vitamin D3 metabolism in patients with rheumatic diseases: low serum levels of 25-hydroxyvitamin D3 in patients with systemic lupus erythematosus. Clin Rheumatol 14:397-400.
261. Cutillas-Marco, E., M. Morales-Suarez-Varela, A. Marquina-Vila, and W. Grant. 2010. Serum 25-hydroxyvitamin D levels in patients with cutaneous lupus erythematosus in a Mediterranean region. Lupus 19:810-814.
262. Cutolo, M. and K. Otsa. 2008. Review: Vitamin D, immunity and lupus. Lupus 17:6-10.
263. Kamen, D. and C. Aranow. 2008. Vitamin D in systemic lupus erythematosus. Curr Opin Rheumatol 20:532-537.
264. Hayes, M. E., J. Denton, A. J. Freemont, and E. B. Mawer. 1989. Synthesis of the active metabolite of vitamin D, 1,25(OH)2D3, by synovial fluid macrophages in arthritic diseases. Ann Rheum Dis 48:723-729.
265. Mawer, E. B., M. E. Hayes, P. E. Still, M. Davies, G. A. Lumb, J. Palit, and P. J. Holt. 1991. Evidence for nonrenal synthesis of 1,25-dihydroxyvitamin D in patients with inflammatory arthritis. J Bone Miner Res 6:733-739.
266. Hayes M. E., O’Donoghue D. J., Ballardie F. W., and E. B. Mawer. 1987. Peritonitis induces the synthesis of 1 alpha,25-dihydroxyvitamin D3 in macrophages from CAPD patients. FEBS Lett 220:307-310.
267. Levy, R., J. Klein, T. Rubinek, M. Alkan, S. Shany, and C. Chaimovitz. 1990. Diversity in peritoneal macrophage response of CAPD patients to 1,25-dihydroxyvitamin D3. Kidney Int 37:1310-1315.
268. Shany, S., J. Rapoport, I. Zuili, A. Gavriel, N. Lavi, and C. Chaimovitz. 1991. Metabolism of 25-OH-vitamin D3 by peritoneal macrophages from CAPD patients. Kidney Int 39:1005-1011.
269. Chun, R. F., A. L. Lauridsen, L. Suon, L. A. Zella, J. W. Pike, R. L. Modlin, A. R. Martineau, R. J. Wilkinson, J. Adams, and M. Hewison. 2010. Vitamin D-binding protein directs monocyte responses to 25-hydroxy- and 1,25-dihydroxyvitamin D. J Clin Endocrinol Metab 95:3368-3376.